IPX Company Profile and Key Details

IPX has shown mixed momentum, gaining 6.07% over the past week and -18.15% over the past quarter, though year-to-date performance is up 32.85%. Short-term trend indicators are bearishly aligned (SMA20 7.65%, SMA50 10.27%, SMA200 24.05%). The stock’s 14-day RSI is 58.52 (neutral), while the ATR of 2.57 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.38% below its high and over 293.56% above its low. Average 10-day trading volume of 251.45 thousand shares is below the 3-month average of 288.73 thousand, indicating normal recent market interest.

IperionX Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.73. This means the shares are trading above this model’s fair value.

IperionX Limited (NASDAQ:IPX) closed at $21.71 USD, losing -$0.79 (-3.51%) from the previous close of $22.50. The stock is currently mid-range between its 52-week high and low $20.05 and $61.45. With a market capitalization of about $728.59 million, IperionX Limited is classified as a small-cap and shows higher-than-market volatility (beta ~1.34). Key stats such as the average daily volume over the past year has been around 289.66 thousand shares, in line with its 52-week average. Headquartered in Charlotte, NC, IperionX Limited operates in the Basic Materials sector and the Other Precious Metals industry. Led by CEO Anastasios Arima, the company employs approximately 28 people and listed since June 21, 2022. IperionX Limited primarily focuses on discovering and developing mineral resource sites.

IperionX Limited has 36.21 million shares outstanding. The public float is 27.32 million shares, elevated short interest at 3.03% of float. This equals 946.29 thousand shares. The short ratio is 2.94 days. Institutional investors hold 14.69% of the float. Insiders own 0.0%. Hannigan Todd holds 26.63 million shares, Arima Anastasios has 12.46 million shares and TUCHMAN MARTIN has 6.71 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

IperionX Limited generated EPS of -$1.20 over the past year. Five-year average earnings growth is -49.42%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 5 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $74.00 to $40.00. The high target offers 240.86% upside. The low target suggests 84.25% downside. The mean target is $59.00. This offers 171.76% upside. IperionX Limited earnings surprise history is a mixed track record. The quarter that ended March 12, 2026, missed forecasts by 150.0%. The prior quarter beat by 2298.9%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in October 21, 2024.

IperionX Limited trades at a P/E ratio of -2.09, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.68 suggesting the stock is closer to book value. The P/FCF stands at -13.64, also below market averages.

IperionX Limited (NASDAQ:IPX) shares are up 32.85% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows IperionX Limited trading at a premium to the broader market with a P/E of -2.09. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $51.12, suggesting 135.47% upside. Our AI forecast model points to short-term strength (2.67% over two weeks), a medium-term fall (-77.89% over three months), and a longer-term gain (55.64% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that IperionX Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.67%, with price expected at $22.29 by September 04, 2026, within a range of $20.71 to $23.96 3-Month Outlook: Projected fall of -77.89%, reaching $4.80 by November 19, 2026, with a range of $3.46 to $5.93. 1-Year Outlook: Projected gain of 55.64%, with price at $33.79 by August 20, 2027, within a range of $31.06 to $36.81.